Joel Pekow

5.4k total citations
116 papers, 3.2k citations indexed

About

Joel Pekow is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Joel Pekow has authored 116 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Genetics, 64 papers in Epidemiology and 33 papers in Surgery. Recurrent topics in Joel Pekow's work include Inflammatory Bowel Disease (72 papers), Microscopic Colitis (53 papers) and Autoimmune and Inflammatory Disorders (14 papers). Joel Pekow is often cited by papers focused on Inflammatory Bowel Disease (72 papers), Microscopic Colitis (53 papers) and Autoimmune and Inflammatory Disorders (14 papers). Joel Pekow collaborates with scholars based in United States, France and Australia. Joel Pekow's co-authors include David T. Rubin, Marc Bissonnette, John H. Kwon, Atsushi Sakuraba, Christopher G. Chapman, Russell D. Cohen, Urszula Dougherty, Sushila Dalal, John Hart and Katherine Meckel and has published in prestigious journals such as Journal of Clinical Investigation, Nature Immunology and Gastroenterology.

In The Last Decade

Joel Pekow

108 papers receiving 3.1k citations

Peers

Countries citing papers authored by Joel Pekow

Since Specialization

Citations

This map shows the geographic impact of Joel Pekow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Pekow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Pekow more than expected).

Fields of papers citing papers by Joel Pekow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Pekow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Pekow. The network helps show where Joel Pekow may publish in the future.

Co-authorship network of co-authors of Joel Pekow

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Pekow. A scholar is included among the top collaborators of Joel Pekow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Pekow. Joel Pekow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tu1882 REAL-WORLD EFFECTIVENESS AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE: A MULTICENTER STUDY 2024 ·Gastroenterology ·(unknown), (unknown), (unknown), Katherine Huang, (unknown), Joel Pekow, Anish Patel, Shrinivas Bishu, (unknown), (unknown), Ryan C. Ungaro, Andrés Yarur, (unknown), Parakkal Deepak	0
2	P848 Risankizumab Effectiveness in Ustekinumab-naïve and Ustekinumab-experienced Patients with Crohn’s Disease- Real-world Data from a Large Tertiary Center 2024 ·Journal of Crohn s and Colitis ·(unknown), D Choi, (unknown), Elise Fear, (unknown), Russell D. Cohen, Sushila Dalal, Noa Krugliak Cleveland, Joel Pekow, David T. Rubin	1
3	P580 Upadacitinib is effective and safe for Ulcerative Colitis: prospective real-world experience 2023 ·Journal of Crohn s and Colitis ·(unknown), D Choi, (unknown), (unknown), Nicole Garcia, (unknown), Nathaniel A. Cohen, R D Cohen, Sushila Dalal, Joel Pekow, Atsushi Sakuraba, Noa Krugliak Cleveland, David T. Rubin	0
4	P724 Upadacitinib is Effective and Safe in Tofacitinib-Experienced Patients with Ulcerative Colitis: A Prospective Real-World Experience 2023 ·Journal of Crohn s and Colitis ·Noa Krugliak Cleveland, (unknown), D Choi, (unknown), (unknown), Nicole Garcia, (unknown), Nathaniel A. Cohen, R D Cohen, Sushila Dalal, Joel Pekow, Atsushi Sakuraba, David T. Rubin	4
5	Comparison of the Risk of Crohn’s Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis 2022 ·Journal of Crohn s and Colitis ·Pauline Rivière, Joel Pekow, Nassim Hammoudi, Pauline Wils, Peter De Cruz, (unknown), Míriam Mañosa, Jacob E. Ollech, Matthieu Allez, Maria Nachury, Michael A. Kamm, (unknown), Marc Ferrante, Anthony Buisson, Siddarth Singh, David Laharie, Momar Diouf, Mathurin Fuméry	17
6	Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease 2021 ·Intestinal Research ·Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, Roger D. Hurst, Neil Hyman, Atsushi Sakuraba, Joel Pekow, Sushila Dalal, Russell D. Cohen, (unknown), David T. Rubin	10
7	Wnt–β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression 2021 ·Nature Immunology ·Jasmin Quandt, Stephen Arnovitz, (unknown), (unknown), (unknown), (unknown), Priya Mathur, Akinola Olumide Emmanuel, (unknown), (unknown), (unknown), Alexander T. Pearson, Randy F. Sweis, Joel Pekow, Christopher R. Weber, Khashayarsha Khazaie, Fotini Gounari	69
8	Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States 2020 ·Crohn s & Colitis 360 ·Edward L. Barnes, Laura H. Raffals, Millie D. Long, Gaurav Syal, Maia Kayal, Ashwin N. Ananthakrishnan, Benjamin L. Cohen, Joel Pekow, Parakkal Deepak, Jean‐Frédéric Colombel, Hans Herfarth, Robert S. Sandler	8
9	Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease 2020 ·Clinical Gastroenterology and Hepatology ·Jacob E. Ollech, (unknown), Noam Peleg, Jingzhou Wang, (unknown), Victoria Rai, Yangtian Yi, (unknown), Sushila Dalal, Atsushi Sakuraba, Russell D. Cohen, David T. Rubin, Joel Pekow	65
10	Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer 2019 ·Cancer Prevention Research ·Urszula Dougherty, Reba Mustafi, (unknown), (unknown), Jeffrey S. Souris, Loren Joseph, John Hart, Vani J. Konda, Wei Zhang, Joel Pekow, Yan Chun Li, Marc Bissonnette	3
11	Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection 2018 ·Surgical Infections ·(unknown), Joel Pekow	5
12	miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD 2017 ·Clinical Cancer Research ·Joel Pekow, Katherine Meckel, Urszula Dougherty, Yong Huang, Xindi Chen, (unknown), Reba Mustafi, (unknown), Zifeng Deng, (unknown), John Hart, David T. Rubin, John H. Kwon, Marc Bissonnette	72
13	The features of mucosa‐associated microbiota in primary sclerosing cholangitis 2016 ·Alimentary Pharmacology & Therapeutics ·Joana Torres, Xiuliang Bao, Aparna Goel, Jean‐Frédéric Colombel, Joel Pekow, Bana Jabrì, (unknown), Anabella Castillo, Joseph A. Odin, Katherine Meckel, Farah Fasihuddin, Inga Peter, Steven H. Itzkowitz, Jianzhong Hu	111
14	ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer 2016 ·Clinical Cancer Research ·Reba Mustafi, Urszula Dougherty, Devkumar Mustafi, (unknown), (unknown), Sarbani Adhikari, (unknown), Katherine Meckel, (unknown), (unknown), Joel Pekow, Vani J. Konda, Loren Joseph, John Hart, Alessandro Fichera, Yan Chun Li, Marc Bissonnette	36
15	The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer 2014 ·Clinical Cancer Research ·Urszula Dougherty, Reba Mustafi, (unknown), (unknown), Devkumar Mustafi, (unknown), (unknown), Weicheng Liu, Vani J. Konda, Joel Pekow, Sharad Khare, John Hart, Loren Joseph, Alice M. Wyrwicz, Gregory S. Karczmar, Yan Chun Li, Marc Bissonnette	36
16	Parastomal Variceal Bleeding Attributed to Obstructive Pathology Successfully Treated by Percutaneous Variceal Embolization 2014 ·ACG Case Reports Journal ·Yutaka Tomizawa, Atsushi Sakuraba, Joel Pekow	1
17	Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis 2013 ·Journal of Clinical Investigation ·Weicheng Liu, Yunzi Chen, Maya Aharoni Golan, Maria Laura Annunziata, Jie Du, Urszula Dougherty, Juan Kong, Mark W. Musch, Yong Huang, Joel Pekow, Chang-Qing Zheng, Marc Bissonnette, Stephen B. Hanauer, Yan Chun Li	268
18	Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions 2013 ·Inflammatory Bowel Diseases ·Joel Pekow, Urszula Dougherty, Yong Huang, (unknown), (unknown), Greg Cohen, Shawn Levy, Masha Kocherginsky, Nanda Venu, Maria Westerhoff, John Hart, Amy Noffsinger, Stephen B. Hanauer, Roger D. Hurst, Alessandro Fichera, Loren Joseph, Qiang Liu, Marc Bissonnette	39
19	EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators 2011 ·Molecular Cancer Research ·(unknown), Urszula Dougherty, Victoria Robinson, Reba Mustafi, Joel Pekow, Sonia S. Kupfer, Yan-Chun Li, John Hart, Kathleen H. Goss, Alessandro Fichera, Loren Joseph, Marc Bissonnette	96
20	Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia 2011 ·American Journal Of Pathology ·Chun‐Chuan Chen, Joel Pekow, Victoria Lladó, (unknown), (unknown), Atsushi Mizoguchi, Mari Mino–Kenudson, Marc Bissonnette, Emiko Mizoguchi	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact